A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers

This study has been terminated.

( Roche has withdrawn support as no longer aligned with their medical strategy for Xeloda )

Study NCT00177255 Information provided by University of Pittsburgh

First Received: September 12, 2005 Last Updated: April 28, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	December 2008
Primary Completion Date:	December 2008 (Final data collection date for primary outcome measure)